Shares of Doximity (NYSE:DOCS) popped in extended trading on Thursday after the company reported third-quarter fiscal 2025 results that beat analysts’ expectations for revenue and offered rosy guidance.
Here’s how the company did:
• Earnings per share: 37 cents, which may not compare with the 34 cents expected by LSEG
• Revenue: $168.6 million vs. $152.8 million expected by LSEG
Doximity is a digital platform for medical professionals that helps clinicians stay current on medical news, manage paperwork, find referrals and carry out telehealth appointments with patients. The company primarily generates revenue through its telehealth tools, hiring solutions and marketing offerings for clients such as pharmaceutical companies.
Doximity’s revenue increased 25% in its third quarter from $135.3 million during the same period last year, according to a release.
For its fiscal fourth quarter, Doximity said it expects to report revenue between $132.5 million and $133.5 million, compared with analysts’ estimates of $123.8 million.
The company also raised guidance for its full fiscal year, and said it expects to report revenue between $564.6 million and $565.6 million, up from the range the company shared last quarter, when it expected $535 million to $540 million. Analysts were expecting $540 million for the year.
DOCS galloped $19.08, or 32.8%, to $77.34.
